Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 19, Status: Authorised

PRAC recommendations on safety signals

List of signals discussed at PRAC since September 2012

PRAC recommendations on signals adopted at the 27-30 October 2025 PRAC meeting

New product information wording: extracts from PRAC recommendations on signals adopted at the 27-30 October 2025 PRAC

PSUSA/00003045/202501

Organisation Management Service (OMS)

Referentials Management Service (RMS)

Vaccines: concerns, questions and false claims

Human medicines European public assessment report (EPAR): Steglujan, ertugliflozin,sitagliptin, Date of authorisation: 23/03/2018, Revision: 14, Status: Authorised